Funding for this research was provided by:
Diabetes UK (11/0004367)
Received: 13 February 2018
Accepted: 19 April 2018
First Online: 2 May 2018
Ethics approval and consent to participate
: The trial was approved by the London–Riverside National Research Ethics Service (NRES) Committee, research ethics committee reference number 12/LO/1742. Consent was sought from practices and healthcare providers participating in the trial. Consent from patients was presumed upon returning a completed questionnaire to maintain anonymity to the research team.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.